The last conference call (feb 26) mentioned many p
Post# of 36537
(Total Views: 425)
Posted On: 05/22/2019 6:41:37 PM
The last conference call (feb 26) mentioned many potential revenue streams, close to completing several acquisitions, public listing for GNBT and spinoff (60-90 days), relation with top tier bank to facilitate expanding, Keytruda/AE37 ph II.
Where are we today, can we assume the feb 26 cc is still valid or are we drifting away, many deals include cash and $2.50/sh.
I understand it's a huge task and plans may change but with little news the cc's and current stock price are the only reference we have ..........
Where are we today, can we assume the feb 26 cc is still valid or are we drifting away, many deals include cash and $2.50/sh.
I understand it's a huge task and plans may change but with little news the cc's and current stock price are the only reference we have ..........
(0)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼